AUROBINDO PHARMA LTD’ (APL). APL is a growing Unit-7, Jadcherlan multinational pharmaceutical manufacturing firm with turnover of over US$2.8 Billion revenues for 2018-19, with presence in more than 34 countries fronted presence with products exported to 155 nations. APL is 2nd Largest Generic Company as per Rx dispensed in the USA.APL is Amongst Top 10 Generic player in France, Germany, Portugal, UK, Italy, Czech Republic, Netherlands & Belgium. APL manufactured 33 Billion+ diverse dosage forms in 2018-19. APL has 27 manufacturing facilities and 5 R&D centres worldwide.